MENINGITEC - MENINGITEC - CT 7079 - English version

Has

Description

Introduction MENINGITEC suspension for injection in prefilled syringes – meningococcal group C oligosaccharide conjugate vaccine (adsorbed) Pack of 1 syringe with stopper + separate needle (CIP: 381 501-0) Posted on Dec 22 2009 Active substance (DCI) Neisseria meningitidis group C (strain C11) oligosaccharide conjugated to CRM197 protein Maladies infectieuses - Pédiatrie - Nouvelle recommandation Progrès thérapeutique majeur dans la prévention des infections dues à Neisseria meningitidis du groupe C chez les sujets de 12 mois à 24 ans révolus Ces trois vaccins sont indiqués dans l’immunisation active des nourrissons à partir de l’âge de 2 mois, des enfants, des adolescents et des adultes pour la prévention des maladies invasives dues à Neisseria meningitidis du sérogroupe C. Ces vaccins doivent être utilisés selon les recommandations du Haut Conseil de la santé publique (HCSP). (http://www.hcsp.fr/docspdf/avisrapports/hcspa20090424_meningC.pdf). Pour en savoir plus télécharger la synthèse ou l'avis complet ci-dessous ATC Code J07AH Laboratory / Manufacturer WYETH PHARMACEUTICALS FRANCE MENINGITEC suspension for injection in prefilled syringes – meningococcal group C oligosaccharide conjugate vaccine (adsorbed) Pack of 1 syringe with stopper + separate needle (CIP: 381 501-0) Posted on Dec 22 2009

Sujets

• Pédiatrie
• Maladie infectieuse
• Médecine

Informations

• Publié par: haute-autorite-sante-maladies-infectieuses
• Publié le: 21 octobre 2009
• Nombre de lectures: 36
• Licence : En savoir +
  Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique
• Langue: English

Extrait

 

 

 

The legally binding text is the original French version   TRANSPARENCY COMMITTEE

OPINION   21 October 2009     MENINGITEC suspension for injection in prefilled syringes – meningococcal group C oligosaccharide conjugate vaccine (adsorbed) Pack of 1 syringe with stopper + separate needle (CIP: 381 501-0)     Applicant: WYETH PHARMACEUTICALS FRANCE   Neisseria meningitidisC (strain C11) oligosaccharide conjugated to CRMgroup 197 protein.     ATC Code: J07AH07   List I   Date of initial MA (mutual recognition procedure): vial: 11/01/2002 prefilled syringe: 12/07/07 - amended 28/01/09     Product included on the list of medicines approved for use by hospitals and various public services.     Reason for request: inclusion on the list of products reimbursed by National Insurance for the new population recommended by the High Council for Public Health: - systematic vaccination of all infants aged 12 to 24 months - systematic vaccination extended up to and including the age of 24 years during the introduction of this new strategy and pending its optimal impact through group immunity.         Additional document: Opinion of the HCPH regarding vaccination with meningococcal serogroup C conjugate vaccine (sessions of April 24 and June 26, 2006) http://www.hcsp.fr/docspdf/avisrapports/hcspa20090424_meningC.pdf                Medical, Economic and Public Health Assessment Division

 

1